#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA677587	B	Inhibitory activity against Human formylpeptide receptor (FPR) of human leukemia HL-60 cells		59		cell-based format	Scientific Literature
2.	ALA677588	B	Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cells		47		cell-based format	Scientific Literature
3.	ALA696696	F	Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neutrophils		8		assay format	Scientific Literature
4.	ALA696697	F	Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neutrophils; NA= No activity at 30 uM		10		assay format	Scientific Literature
5.	ALA699999	F	Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophils		15		assay format	Scientific Literature
6.	ALA820116	B	Binding affinity towards fMLF receptor using human neutrophils		23		single protein format	Scientific Literature
7.	ALA911152	B	Inhibition of human fMLP receptor at 10 uM	Homo sapiens	1		single protein format	Scientific Literature
8.	ALA853681	F	Inhibition of fMLP-induced human neutrophil chemotaxis	Homo sapiens	1		assay format	Scientific Literature
9.	ALA887899	B	Displacement of [3H]-fMLP from FPR in human neutrophils	Homo sapiens	13		single protein format	Scientific Literature
10.	ALA925629	F	Agonist activity at human recombinant FPR expressed in CHO cells assessed as calcium flux by aequorin based bioluminescence assay	Homo sapiens	15		cell-based format	Scientific Literature
11.	ALA1919337	F	Antagonist activity at human FPR1 in human neutrophils assessed as inhibition of fMLF-stimulated intracellular calcium mobilisation by FLIPR assay	Homo sapiens	39		cell-based format	Scientific Literature
12.	ALA1919338	F	Antagonist activity at human FPR1 in human neutrophils assessed as inhibition of fMLF-stimulated intracellular calcium mobilisation at 50 uM by FLIPR assay	Homo sapiens	4		cell-based format	Scientific Literature
13.	ALA1919521	F	Antagonist activity at FPR1 in whole blood assessed as CD11 level		2		tissue-based format	Scientific Literature
14.	ALA1937756	F	Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisation after 1 hr by FLIPR assay	Homo sapiens	20		cell-based format	Scientific Literature
15.	ALA1937830	F	Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisation at 30 uM after 1 hr by FLIPR assay	Homo sapiens	2		cell-based format	Scientific Literature
16.	ALA1937831	F	Antagonist activity at FPR1 in human neutrophils assessed as AB/fMLF-stimulated upregulation of CD11b expression preincubated for 30 mins before AB/FMLF challenge measured after 50 mins using FITC staining by flow cytometry	Homo sapiens	2		assay format	Scientific Literature
17.	ALA1952675	B	Activity at human FPR1 receptor at 10 uM	Homo sapiens	1		single protein format	Scientific Literature
18.	ALA1051689	F	Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assay		44		cell-based format	Scientific Literature
19.	ALA1051692	F	Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assay	Homo sapiens	13		cell-based format	Scientific Literature
20.	ALA1051694	F	Agonist activity at FPR1 in human neutrophiles by chemotaxis assay	Homo sapiens	13		assay format	Scientific Literature